Key result
Patients with ischemic dilated cardiomyopathy had a higher mean calcium echo score than those with nonischemic etiology, with a score ≥3 present in.
Why the study?
Does the assessment of cardiac calcification by two-dimensional echocardiography distinguish ischemic from nonischemic dilated cardiomyopathy in patients with LVEF <40%?
Cross-Sectional (n=62)
Does the assessment of cardiac calcification by two-dimensional echocardiography distinguish ischemic from nonischemic dilated cardiomyopathy in patients with LVEF <40%?
A simple echocardiographic calcium score can help noninvasively distinguish ischemic from nonischemic etiology in patients with dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support noninvasive etiology differentiation in dilated cardiomyopathy; hypothesis-generating and requires prospective validation before clinical adoption.
BACKGROUND: Aortic valve calcification (AVC) and/or mitral annulus calcification (MAC) is considered to be a marker of atherosclerosis and has been demonstrated to predict cardiovascular morbidity and mortality. AIM: We hypothesized that the presence of cardiac calcification by echocardiography can be used in the differential diagnosis between ischaemic (DCMI+) and nonischaemic dilated cardiomyopathy (DCMI-). METHODS: We evaluated 62 patients with DCM (38 males, mean age 66 +/- 10 years, LVEF < 40%), without any prior history of myocardial infarction or coronary intervention, who were undergoing coronary angiography for aetiological diagnosis. DCMI+ was considered present when a > or = 70% stenosis of at least one coronary artery was found. AVC, MAC, aortic wall and papillary muscle calcifications were semiquantitatively assessed by two-dimensional echocardiographic examination with a calcium score ranging from 0 (no calcifications) to 8 (calcium in all four sites). RESULTS: DCMI+ was found in 20 out of 62 patients. As expected, there were no differences in LVEF and LV end-diastolic diameters between DCMI+ and DCMI--patients (29 +/- 8% versus 31 +/- 10% and 66 +/- 6 versus 68 +/- 8 mm, respectively; not significant). Regional wall motion abnormalities and conventional risk factors for atherosclerosis, such as hypertension and hypercholesterolaemia, were significantly more frequent in the DCMI+ compared to the DCMI- group. On the other hand, the calcium echo score was 4.6 +/- 2 (range 1.7-7.3) in DCMI+ patients and 0.8 +/- 0.95 (range 0-4) in DCMI--patients (P < 0.05). A calcium score > or = 3 was observed in 18 out of 20 (90%) DCMI+ patients and only in three of 42 (8%) DCMI--patients. CONCLUSIONS: The assessment of cardiac calcification by two-dimensional echocardiography could represent a simple, noninvasive and inexpensive approach to assess the aetiology (ischaemic versus nonischaemic) of dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Faggiano et al. (2006) conducted a cross-sectional in Dilated cardiomyopathy (n=62). Ischemic dilated cardiomyopathy (DCMI+) vs. Nonischemic dilated cardiomyopathy (DCMI-) was evaluated on Mean calcium echo score (p=<0.05). Patients with ischemic dilated cardiomyopathy had a higher mean calcium echo score than those with nonischemic etiology, with a score ≥3 present in.
Synapse has enriched 10 related papers. Consider them for comparative context: